Topic

Defitelio (defibrotide)

A collection of 30 issues

How to Get Defitelio (defibrotide) Covered by Humana in California: Prior Authorization Forms, Appeal Process, and Timeline

Quick Answer: Getting Defitelio Covered by Humana in California Defitelio (defibrotide) requires prior authorization under all Humana Medicare Advantage plans in California. The fastest path to approval: (1) Confirm your plan type via MyHumana portal, (2) Download Humana's 2025 Medicare Prior Authorization form, and (3) Submit with complete

How to Get Defitelio (Defibrotide) Covered by Cigna in Ohio: Appeals Process and State Review Rights

Answer Box: Getting Defitelio Covered by Cigna in Ohio Defitelio (defibrotide) requires prior authorization from Cigna for hepatic veno-occlusive disease with renal/pulmonary dysfunction post-HSCT. Your physician calls 1-800-882-4462 or submits via ExpressPAth for 24-72 hour review. If denied, you have 180 days to file internal appeals with Cigna, then

How to Get Defitelio (Defibrotide) Covered by Cigna in New Jersey: Complete PA Guide and Appeals Process

Answer Box: Getting Defitelio Covered by Cigna in New Jersey Defitelio (defibrotide) requires prior authorization from Cigna for hepatic VOD/SOS with organ dysfunction post-stem cell transplant. Your transplant physician should call Cigna at 1-800-882-4462 for expedited 72-hour approval. If denied, you have 180 days to file internal appeals, then

How to Get Defitelio (Defibrotide) Covered by Humana in Ohio: Prior Authorization, Appeals, and Cost-Saving Strategies

Answer Box: Getting Defitelio Covered by Humana in Ohio Defitelio (defibrotide) requires prior authorization from Humana Medicare Advantage plans in Ohio. Your prescriber must submit medical necessity documentation proving hepatic veno-occlusive disease (VOD) or sinusoidal obstruction syndrome (SOS) post-HSCT with supporting labs and clinical notes. If denied, you have 65

Getting Defitelio (Defibrotide) Covered by Blue Cross Blue Shield in New York: PA Requirements, Appeals, and Cost Assistance

Answer Box: Getting Defitelio Covered by Blue Cross Blue Shield in New York Defitelio (defibrotide) requires prior authorization from Blue Cross Blue Shield plans in New York for hepatic veno-occlusive disease (VOD) with organ dysfunction post-HSCT. Your fastest path: (1) Have your transplant team submit PA with VOD diagnosis documentation

How to Get Defitelio (defibrotide) Covered by Cigna in North Carolina: Complete PA Guide and Appeals Process

Answer Box: Getting Defitelio Covered by Cigna in North Carolina Defitelio (defibrotide) requires prior authorization from Cigna for hepatic veno-occlusive disease (VOD/SOS) with organ dysfunction post-stem cell transplant. Submit PA through electronic portals like CoverMyMeds or Evicore for fastest approval (often same-day). Include HSCT details, VOD/SOS diagnosis with

How to Get Defitelio (Defibrotide) Covered by Blue Cross Blue Shield in New Jersey: Complete Timeline Guide and Appeal Templates

Answer Box: Getting Defitelio Covered in New Jersey Defitelio (defibrotide) requires prior authorization from Horizon Blue Cross Blue Shield of New Jersey for hepatic VOD/SOS with organ dysfunction after HSCT. Submit urgent PA requests within 24 hours for life-threatening cases. If denied, file internal appeals within 180 days, then

How Long Does It Take to Get Defitelio (Defibrotide) Approved by UnitedHealthcare in Washington? Complete Timeline Guide

Quick Answer: UnitedHealthcare typically processes Defitelio (defibrotide) prior authorization requests within 3-7 business days for standard review, or 24-72 hours for expedited cases involving hepatic VOD/SOS after HSCT. In Washington, if denied, you have 180 days to appeal internally, followed by external review through an Independent Review Organization (IRO)

How to Get Defitelio (Defibrotide) Covered by Aetna CVS Health in Illinois: Complete Guide with Forms and Appeals

Answer Box: Getting Defitelio Covered by Aetna in Illinois Defitelio (defibrotide) requires prior authorization from Aetna CVS Health for severe hepatic veno-occlusive disease (VOD/SOS) with organ dysfunction post-HSCT. Submit PA through Aetna provider portal with complete transplant records, organ dysfunction evidence, and FDA indication match. If denied, file internal

Work With Your Doctor to Get Defitelio (Defibrotide) Approved by Aetna (CVS Health) in California: Complete Guide With Forms and Appeals

Answer Box: Getting Defitelio (Defibrotide) Approved by Aetna (CVS Health) in California Defitelio (defibrotide) requires prior authorization from Aetna (CVS Health) for severe hepatic veno-occlusive disease (VOD/SOS) with organ dysfunction post-stem cell transplant. The fastest path to approval: (1) Have your transplant team submit the PA through Aetna'